Our results confirm that MAPK4 promotes glioma progression by facilitating proliferation and migration both in vitro and in vivo, consistent with the previously reported roles of MAPK4 in breast cancer and prostate cancer.10, 11, 12. Here, MAPK4 is linked to central nervous system cancer.